JP2024507451A5 - - Google Patents
Info
- Publication number
- JP2024507451A5 JP2024507451A5 JP2023546555A JP2023546555A JP2024507451A5 JP 2024507451 A5 JP2024507451 A5 JP 2024507451A5 JP 2023546555 A JP2023546555 A JP 2023546555A JP 2023546555 A JP2023546555 A JP 2023546555A JP 2024507451 A5 JP2024507451 A5 JP 2024507451A5
- Authority
- JP
- Japan
- Prior art keywords
- cas
- fusion protein
- linker
- domain
- repressor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163146419P | 2021-02-05 | 2021-02-05 | |
| US63/146,419 | 2021-02-05 | ||
| PCT/US2022/015162 WO2022170007A1 (en) | 2021-02-05 | 2022-02-04 | Fusion proteins for crispr-based transcriptional repression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507451A JP2024507451A (ja) | 2024-02-20 |
| JP2024507451A5 true JP2024507451A5 (enExample) | 2025-02-10 |
Family
ID=82741783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023546555A Pending JP2024507451A (ja) | 2021-02-05 | 2022-02-04 | Ｃｒｉｓｐｒに基づく転写抑制用融合タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240309347A1 (enExample) |
| EP (1) | EP4288548A4 (enExample) |
| JP (1) | JP2024507451A (enExample) |
| CN (1) | CN117062912A (enExample) |
| CA (1) | CA3210492A1 (enExample) |
| WO (1) | WO2022170007A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2024230979A1 (en) * | 2023-03-06 | 2025-10-16 | Nchroma Bio, Inc. | Compositions and methods for epigenetic regulation of pcsk9 expression |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5244103B2 (ja) * | 2006-08-09 | 2013-07-24 | ホームステッド クリニカル コーポレイション | 器官特異的蛋白質およびその使用方法 |
| US20110211997A1 (en) * | 2008-07-28 | 2011-09-01 | Forbes Oil And Gas Pty. Ltd. | Apparatus for liquefaction of carbonaceous material |
| SG10201912991WA (en) * | 2012-12-17 | 2020-03-30 | Harvard College | Rna-guided human genome engineering |
| WO2016094872A1 (en) * | 2014-12-12 | 2016-06-16 | The Broad Institute Inc. | Dead guides for crispr transcription factors |
| WO2016138340A1 (en) * | 2015-02-27 | 2016-09-01 | Saint Louis University | Tumor suppressor sall1 as a therapeutic agent for treating cancer |
| US11629342B2 (en) * | 2017-10-17 | 2023-04-18 | President And Fellows Of Harvard College | Cas9-based transcription modulation systems |
| US11957695B2 (en) * | 2018-04-26 | 2024-04-16 | The Broad Institute, Inc. | Methods and compositions targeting glucocorticoid signaling for modulating immune responses |
| JP2022511390A (ja) * | 2018-11-20 | 2022-01-31 | ユニバーシティ オブ ワシントン | 分割インターロイキン模倣体およびその使用 |
-
2022
- 2022-02-04 EP EP22750411.5A patent/EP4288548A4/en active Pending
- 2022-02-04 US US18/275,442 patent/US20240309347A1/en active Pending
- 2022-02-04 CN CN202280013654.0A patent/CN117062912A/zh active Pending
- 2022-02-04 JP JP2023546555A patent/JP2024507451A/ja active Pending
- 2022-02-04 CA CA3210492A patent/CA3210492A1/en active Pending
- 2022-02-04 WO PCT/US2022/015162 patent/WO2022170007A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Studzinski et al. | Participation of c-myc protein in DNA synthesis of human cells | |
| Nobori et al. | Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | |
| CN112040988A (zh) | 修饰的aav衣壳多肽用于治疗肌肉疾病 | |
| Satyamoorthy et al. | The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: pleiotropic effects of YY1 on distinct DNA promoter elements | |
| JP2008200041A (ja) | モジュラートランスフェクション系 | |
| CN102741405A (zh) | 提高基因表达的系统和保持有该系统的载体 | |
| JP2025073123A5 (enExample) | ||
| JP2010029207A (ja) | ＨＭＧ蛋白質（ｈｉｇｈｍｏｂｉｌｉｔｙｇｒｏｕｐｐｒｏｔｅｉｎ）遺伝子の核酸配列およびそれらの使用 | |
| WO2022095853A1 (zh) | 一种溶酶体靶向的核酸嵌合体的制备及应用 | |
| JP2829405B2 (ja) | 機能性ポリペプチド | |
| JP2006523448A5 (enExample) | ||
| JPH11503011A (ja) | 条件発現系 | |
| JPH025869A (ja) | Ｄｎａ配列、組換えｄｎａ分子及びリポコルチン類３、４、５並びに６の製造方法 | |
| CN118063584A (zh) | 促肿瘤焦亡蛋白、靶向her2免疫促肿瘤焦亡蛋白及其编码基因与应用 | |
| CN107827970B (zh) | 一种抑制foxm1的抗肿瘤蛋白肽 | |
| JP3373856B2 (ja) | Ｇｐ１３０に全く結合することができないヒトインターロイキン−６の拮抗薬、および医薬化合物の製造におけるそれらの使用 | |
| Broeker et al. | The Mixed Lineage Leukemia (MLL) Protein Involved in 11 q23 Translocations Contains a Domain that Binds Cruciform DNA and Scaffold Attachment Region (SAR) DNA | |
| JP2018526987A (ja) | 腫瘍抑制ペプチド | |
| JPH02291267A (ja) | α―フェトプロテイン遺伝子のエンハンサーに結合する蛋白質をコードするＤＮＡ | |
| Cochrane et al. | Purification of biologically active human immunodeficiency virus rev protein from Escherichia coli | |
| CN106831975B (zh) | 热休克转录因子1在调控15kDa硒蛋白表达中的应用 | |
| JPWO2003078460A1 (ja) | ペプチド、該ペプチドを含有する医薬組成物及び癌治療用医薬組成物 | |
| CN115851793A (zh) | 一种高效表达猪pfkfb3基因的真核表达载体及其构建方法 | |
| Skowron et al. | DNA-FACE™-An Escherichia coli-based DNA Amplification-Expression Technology for Automatic Assembly of Concatemeric ORFs and Proteins | |
| JP2017070224A (ja) | 遺伝子発現用カセット及びその産生物 |